| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/08/2009 | US20090011468 Method for improving protein production |
| 01/08/2009 | US20090011467 Novel fructosyl peptide oxidase |
| 01/08/2009 | US20090011466 Concatameric immunoadhesion molecule |
| 01/08/2009 | US20090011464 Humanized immunoglubulin reactive with alph4beta7 integrin |
| 01/08/2009 | US20090011460 Calcium-binding photoprotein, gene encoding the same, and use thereof |
| 01/08/2009 | US20090011455 Disease model incorporation into an artificial immune system (ais) |
| 01/08/2009 | US20090011453 Methods for Producing Proteins Using Hamster Igf-1 |
| 01/08/2009 | US20090011418 Functional toll-like receptors (tlr) on melanocytes and melanoma cells and uses thereof |
| 01/08/2009 | US20090011409 Antibodies Against Cells of Fetal Origin |
| 01/08/2009 | US20090011400 Substrate switched ammonia lyases and mutases |
| 01/08/2009 | US20090011056 Lingonberry extract, methods of preparing, and uses thereof |
| 01/08/2009 | US20090011051 Methods, Compositions and Articles of Manufacture for HIF Modulating Compounds |
| 01/08/2009 | US20090011004 Improved carriers for delivery of nucleic acid agents to cells and tissues |
| 01/08/2009 | US20090010996 Human antibiotic proteins |
| 01/08/2009 | US20090010983 Alginate Coated, Polysaccharide Gel-Containing Foam Composite, Preparative Methods, and Uses Thereof |
| 01/08/2009 | US20090010962 Genetically Engineered Swine Influenza Virus and Uses Thereof |
| 01/08/2009 | US20090010951 Epitope/Peptide Recognized By Hla-A2402-Restricted Ep/Cam-Specific Ctl And Use Of The Same |
| 01/08/2009 | US20090010950 Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof |
| 01/08/2009 | US20090010949 Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting |
| 01/08/2009 | US20090010948 Anti-tumor vaccines delivered by dendritic cells devoid of interleukin-10 |
| 01/08/2009 | US20090010946 Novel Stromal Cell-Derived Factor-1 Polypeptides, Polynucleotides, Modulators Thereof and Methods of Use |
| 01/08/2009 | US20090010942 Novel primate chitinases and uses therefor |
| 01/08/2009 | US20090010941 Methods for treating HIV |
| 01/08/2009 | US20090010936 Novel Stra6 Polypeptides |
| 01/08/2009 | US20090010934 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
| 01/08/2009 | US20090010933 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors |
| 01/08/2009 | US20090010931 restoring growth inhibition sensitivity to a tumor cell resistant to growth inhibition by HER2 antagonists; antibody produced by the hybridoma 4F10; PC-Cell Derived Growth Factor (PCDGF) |
| 01/08/2009 | US20090010930 Antibodies to vla-1 |
| 01/08/2009 | US20090010925 Antibody variants |
| 01/08/2009 | US20090010924 Apoptotic Anti-IgE Antibodies |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | US20090010901 adipocytes stably maintain a foreign gene encoding a protein that is secreted outside of cells; cells suitable for gene therapy, which can replace bone marrow cells and liver cells used for conventional ex vivo gene therapy |
| 01/08/2009 | US20090010900 Embryonic Stem Cell Derivatives, and Methods of Making and Using the Same |
| 01/08/2009 | US20090010897 Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same |
| 01/08/2009 | US20090010896 Methods and compositions for optimized expansion and implantation of mesenchymal stem cells |
| 01/08/2009 | US20090010895 Isolated cells and populations comprising same for the treatment of CNS diseases |
| 01/08/2009 | US20090010875 IL-7 Fusion Proteins |
| 01/08/2009 | US20090010872 Chimeric soluble hyper il-11 and use thereof |
| 01/08/2009 | US20090010847 Connective Tissue Growth Factor-4 |
| 01/08/2009 | US20090010843 Methods of Identifying Antibodies to Ligands of Orphan Receptors |
| 01/08/2009 | US20090010842 Methods for the early diagnosis of ovarian cancer |
| 01/08/2009 | US20090010841 Antiproliferative agents; as chimeric molecules to direct an effector (e.g. a cytotoxin, an imaging reagent, a drug, etc.) to a prostate tumor site; single chain antibody |
| 01/08/2009 | US20090010840 BISPECIFIC SINGLE CHAIN Fv ANTIBODY MOLECULES AND METHODS OF USE THEREOF |
| 01/08/2009 | US20090008328 Composite Materials Comprising Supported Porous Gels |
| 01/08/2009 | CA2692417A1 Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting |
| 01/08/2009 | CA2692257A1 Modification of plant flavonoid metabolism |
| 01/08/2009 | CA2691975A1 Single pluripotent stem cell culture |
| 01/08/2009 | CA2691868A1 Immortalized avian cell lines |
| 01/08/2009 | CA2691793A1 Automated method and apparatus for embryonic stem cell culture |
| 01/08/2009 | CA2691790A1 Low rigidity gels for msc growth modulation |
| 01/08/2009 | CA2691626A1 Pseudomonas aeruginosa-outer membrane protein pa4710 |
| 01/08/2009 | CA2691427A1 Methods and compositions for optimized expansion and implantation of mesenchymal stem cells |
| 01/08/2009 | CA2689155A1 Cho cell |
| 01/07/2009 | EP2011886A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/07/2009 | EP2011878A1 Vectors for cloning |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011875A1 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| 01/07/2009 | EP2011874A1 Recombinant gelatin in vaccines |
| 01/07/2009 | EP2011873A2 Tumor necrosis factor receptor-associated factors |
| 01/07/2009 | EP2011870A1 Mutant polypeptide having effector function |
| 01/07/2009 | EP2011869A1 Novel anti-cd98 antibody |
| 01/07/2009 | EP2011868A1 Modified creatinine amide hydrolase having improved affinity for substrate, and reagent composition for determination of creatinine |
| 01/07/2009 | EP2011864A1 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
| 01/07/2009 | EP2011863A1 Stimulation of hematopoiesis by ex vivo activated immune cells |
| 01/07/2009 | EP2011862A1 Method for manufacturing an active component of a medicine or diagnosis agent in MDCJ cell suspension culture |
| 01/07/2009 | EP2010662A2 Novel gene disruptions, compositions and methods relating thereto |
| 01/07/2009 | EP2010647A2 Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy |
| 01/07/2009 | EP2010646A2 Cellular labeling and quantification for nuclear magnetic resonance techniques |
| 01/07/2009 | EP2010567A2 Antibody compositions and methods for treatment of neoplastic disease |
| 01/07/2009 | EP2010565A1 Method for recombinant protein production in cho cells |
| 01/07/2009 | EP2010209A2 Immunogenic wt-1 peptides and methods of use thereof |
| 01/07/2009 | EP1963506A4 Compositions and methods for increasing production of recombinant gamma-carboxylated proteins |
| 01/07/2009 | EP1877417A4 Ubiquilin regulation of presenilin endoproteolysis, and suppression of polyglutamine-induced toxicity in cells |
| 01/07/2009 | EP1794191A4 Molecules with effects on cellular development and function |
| 01/07/2009 | EP1730262A4 Modulation of cell intrinsic strain to control cell modulus, matrix synthesis, secretion, organization, material properties and remodeling of tissue engineered constructs |
| 01/07/2009 | EP1624748A4 A transgenic animal model for cancer and stem cells |
| 01/07/2009 | EP1532239B1 Methods and compositions for targeting secretory lysosomes |
| 01/07/2009 | EP1505149B1 Methylotroph yeast producing mammalian type sugar chain |
| 01/07/2009 | EP1504030B1 Constitutively translocating cell line |
| 01/07/2009 | EP1474434B1 The eaat2 promoter and uses thereof |
| 01/07/2009 | EP1425297B1 Isolation of neural stem cells using gangliosides and other surface markers |
| 01/07/2009 | EP1409684B1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/07/2009 | EP1317559B1 Dna transfection system for the generation of infectious negative strand rna virus |
| 01/07/2009 | EP1257290B1 Method for antigen-specific stimulation of t-lymphocytes with synthetic peptide libraries |
| 01/07/2009 | EP1223973B1 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization |
| 01/07/2009 | EP1203087B1 Transgenically modified plant cells and plants having modified gbssi- and be-protein activity |
| 01/07/2009 | EP1200590B1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 01/07/2009 | EP1198581B1 Method for reducing the antigenicity of adeno-associated virus structural protein |
| 01/07/2009 | EP1147180B1 Propagation of bovine coronavirus in chinese hamster ovary cells |
| 01/07/2009 | EP1135114B1 Method for reducing free-radical induced injury in vitro |
| 01/07/2009 | EP1127065B1 Chlamydia antigen and corresponding dna fragments and uses thereof |
| 01/07/2009 | EP1124984B1 Host cells expressing recombinant human erythropoietin |
| 01/07/2009 | EP1115874B1 Alzheimer's disease secretase |
| 01/07/2009 | EP1012293B1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 01/07/2009 | EP1009725B1 13c,15n,2h labeled proteins for nmr structure determinations and their preparation |
| 01/07/2009 | EP0981604B1 Targeted gene modification by parvoviral vectors |
| 01/07/2009 | EP0966537B1 Fasciola hepatica vaccines |
| 01/07/2009 | EP0870046B1 Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis |
| 01/07/2009 | EP0759985B1 Transgenic arthritic mice |
| 01/07/2009 | CN101341247A Methods and reagents for genotyping hcv |